A Genome-Wide Study of Cytogenetic Changes in Colorectal Cancer Using SNP Microarrays: Opportunities for Future Personalized Treatment
Table 5
Approved antibody, antagonist, inhibitor drugs targeted against genes in amplified regions in CRC.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Approved antibody, antagonist, inhibitor drugs targeted against genes in amplified regions in CRC.